DPIIT recognised startup Government of India
Startup India
Unipharma Products Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.9 Cr
▼ 2% YoY
Net profit · FY 2024
₹51.41 Lakh
Net margin 13.2%
EBITDA · FY 2024
₹70.07 Lakh
EBITDA margin 18%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Unipharma Products Private Limited
Data last updated:
Unipharma Products Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 10 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2019PTC344181. Its GSTIN is 07AACCU3646H1ZA (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anshit Bansal and Rakesh Kumar Bansal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 198/23 – B S/F Ramesh Market Garhi East Of Kailash, Delhi, India – 110065.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.9 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹51.41 Lakh (net margin 13.2%) and EBITDA of ₹70.07 Lakh (EBITDA margin 18%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 94% over five years.
Unipharma Products Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0001009). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unipharma.in.
Company details
CIN U74999DL2019PTC344181
Registration Number 344181
Incorporation Date 10 January 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0001009
Recognitions & Rankings of Unipharma Products
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0001009
Contact details
Unipharma Products Private Limited's registered office is in Delhi, Delhi. Its website is unipharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address198/23 – B S/F Ramesh Market Garhi East Of Kailash, Delhi, India – 110065
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Unipharma Products Private Limited, buy the company report.
Comprehensive company report
Unipharma Products Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Unipharma Products is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Unipharma Products Private Limited, buy the company report.
Financials of Unipharma Products Private Limited
FY 2025 filings availableUnipharma Products Private Limited reported revenue of ₹3.9 Cr (down 2% YoY) for FY 2024.
Revenue · FY 2024
₹3.9 Cr ▼ 2%
Net profit · FY 2024
₹51.41 Lakh margin 13.2%
EBITDA · FY 2024
₹70.07 Lakh margin 18%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 11%
5 years · compounded
▲ 94%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 15%
5 years · compounded
▲ 165%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 94%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18% | ||||
| Net Profit Margin | 13.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unipharma Products Private Limited, buy the company report.
Board of directors of Unipharma Products Private Limited
Unipharma Products has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshit Bansal Also directs: Bay Boutique Private Limited | Director | 10 Jan 2019 | 7 Years 9 Months | Current |
| Rakesh Kumar Bansal | Director | 10 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Unipharma Products Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Radscan Systems Private Limited | ₹3.91 Cr (FY 2024) | 4.0% | New Delhi, Delhi, India | |||
| Tekno Derm Mediequip Private Limited | ₹3.91 Cr (FY 2018) | 0.0% | New Delhi, Delhi, India | |||
| Ackermann Medical Private Limited | ₹3.91 Cr (FY 2024) | 69.0% | New Delhi, Delhi, India | |||
| Unipharma Products Private Limitedthis company | ₹3.9 Cr (FY 2024) | ₹51.41 Lakh | 13.2% | -2.0% | Delhi, India |
To see the full peer comparison of Unipharma Products Private Limited, buy the company report.
Auditor
Unipharma Products Private Limited is audited by DEEPAK KUMAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK KUMAR & CO | FY 2021 | 024751N |
Shareholding
The shareholding of Unipharma Products Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unipharma Products Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unipharma Products Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unipharma Products Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unipharma Products has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCU3646H1ZA | Delhi | Active | 12 Jan 2019 |
| 27AACCU3646H1Z8 | Maharashtra | Active | 20 Jul 2019 |
To see the full GST registrations and return filing status of Unipharma Products Private Limited, buy the company report.
Recent activity
Unipharma Products Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Anshit Bansal was appointed as Director on 10 Jan 2019.
AGM
Unipharma Products Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Unipharma Products Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Anshit Bansal was appointed as Director.
Appointed
Rakesh Kumar Bansal was appointed as Director.
Incorporation
10 Jan 2019
Unipharma Products Private Limited was registered on 10 Jan 2019 with Roc Delhi I & aged 7 years 9 months as per MCA records.
Frequently asked questions
Unipharma Products is an active private limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 10 January 2019 (7+ years old) and is registered under CIN U74999DL2019PTC344181.
Unipharma Products has 2 current directors:
- Anshit Bansal - Director
- Rakesh Kumar Bansal - Director
The latest financial statements of Unipharma Products on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Unipharma Products is 07AACCU3646H1ZA, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AACCU3646H1Z8 (Maharashtra).
The CIN (Corporate Identification Number) of Unipharma Products is U74999DL2019PTC344181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unipharma Products was incorporated on 10 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Unipharma Products by revenue are Radscan Systems Private Limited, Tekno Derm Mediequip Private Limited, Ackermann Medical Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Anshit Bansal was appointed as Director on 10 Jan 2019. Rakesh Kumar Bansal was appointed as Director on 10 Jan 2019.
Yes, Unipharma Products is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Unipharma Products is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0001009).
Unipharma Products can be reached through the website unipharma.in. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages